azathioprine has been researched along with ganciclovir in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (28.26) | 18.2507 |
2000's | 17 (36.96) | 29.6817 |
2010's | 14 (30.43) | 24.3611 |
2020's | 2 (4.35) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Buturović-Ponikvar, J; Kandus, A; Kveder, R; Malovrh, M; Ponikvar, R | 1 |
Cook, DJ; Duncan, SR | 1 |
Barker, F; Benjamin, IS; Frankel, AH; Lechler, R; Rees, AJ; Williams, G | 1 |
Dumler, F; Schmidt, RJ; Venkat, KK | 1 |
Dunn, DL; Fasola, CG; Kramer, MA; Loeffler, CM; Matas, AJ; Mayoral, JL; Najarian, JS; Orrom, WJ | 1 |
Bell, PR; Donnelly, PK; Flower, AJ; Nicholson, ML; Veitch, PS | 1 |
Adams, MB; Johnson, CP; O'Hair, DP; Roza, AM | 1 |
Fisher, RA; Godkin, RR; Ham, JM; Posner, MP; Shelden, SL | 1 |
Dunn, DL; Gillingham, KJ; Kramer, MA; Mayoral, JL; Sawyer, MD | 1 |
Behrend, M; Brunkhorst, R; Eberhard, OK; Kliem, V; Koch, KM; Oldhafer, K; Pichlmayr, R; Schaumann, D; Schlitt, HJ | 1 |
Boulieu, R | 1 |
Alonso, EM; Kelly, SM; Newell, KA; Rubin, CM; Thistlethwaite, JR; Whitington, PF | 1 |
Conti, DJ; Hahn, A; Isenberg, A; Shen, GK; Singh, TP | 1 |
Dockrell, DH; Munn, SR; Paya, CV; Sarmiento, JM; Schwab, TR | 1 |
Conti, DJ; Hahn, A; Isenberg, AL; Shen, GK; Singh, TP | 1 |
Brumble, LM; Dummer, JS; Ely, EW; Loyd, JE; Milstone, AP; Pierson, RN; Roberts, JR | 1 |
Orteu, CH; Orton, DI; Rustin, MH | 1 |
Ancelet, D; Blancho, G; Cantarovich, D; Daguin, P; Dantal, J; Giral, M; Hourmant, M; Josien, R; Nguyen, JM; Soulillou, JP | 1 |
Bernal, I; Cabré, E; Domènech, E; García-Planella, E; Gassull, MA | 1 |
Alvarez, E; Bañares, R; Barrio, J; Clemente, G; de Diego, A; Núñez, O; Palomo, J; Pérez Calle, JL; Salcedo, M | 1 |
Bang, S; Hwang, MH; Kang, BS; Kim, HK; Lee, SK; Park, MC; Park, YB | 1 |
Hamlin, PJ; Howdle, PD; Scott, N; Shah, MN; Wyatt, JI | 1 |
Bermejo, J; Bouza, E; Carbone, J; Catalan, P; Fernández-Cruz, E; Fernàndez-Yáñez, J; Muñoz, P; Palomo, J; Rodríguez-Molina, JJ; Sarmiento, E | 1 |
Coderre, S; Horne, G; Medlicott, SA; Panaccione, R | 1 |
Cheung, WW; Hwang, GY; Kwong, YL; Tse, E | 1 |
Ackermann, F; Blétry, O; Burdy, G; Charles, P; Kahn, JE; Leport, J | 1 |
Belkahla, N; Ben Hriz, F; Ben Mami, N; Chaabouni, H; Chouaib, S; Habbessi, H; Maamouri, N; Ouerdiane, S; Ouerghi, H | 1 |
Bataille, S; Berland, Y; Dussol, B; Gaudart, J; Indreies, M; Moal, V; Purgus, R; Vacher-Coponat, H; Zandotti, C | 1 |
Abdulbaki, A; Aoun, EG; Baidoo, L; Hashash, JG; Refaat, M | 1 |
Dickson, M; Eliadou, E; Ferguson, P; Goossens, L; Stace, NH; Weinkove, R | 1 |
Cheifetz, AS; Feuerstein, JD; Feuerstien, JD; Najarian, R | 1 |
Gartner, B; Issekutz, A; Kárász, T; Kullmann, T; Oláh, A; Rácz, I | 1 |
Kramer, MH; Möhlmann, MC; Stiksma, J | 1 |
Abbara, A; Cockbain, BC; Cooke, G; Mora Peris, B; So, CW | 1 |
Chambers, L; Devereux, G; Hawthorne, TZ; Shellien, R | 1 |
Mashimo-Matsuo, Y; Masuo, K; Mizuno, M; Nabeshima, M; Nio-Tamaoki, M; Okae, S; Tanaka, J; Yamaga, Y | 1 |
2 review(s) available for azathioprine and ganciclovir
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Systemic cytomegalovirus infection complicating ulcerative colitis: a case report and review of the literature.
Topics: Adult; Antiviral Agents; Azathioprine; Colitis, Ulcerative; Cytomegalovirus Infections; Ganciclovir; Hepatitis; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Male; Opportunistic Infections | 2004 |
4 trial(s) available for azathioprine and ganciclovir
Article | Year |
---|---|
Treatment of recurrent cytomegalovirus disease in patients receiving solid organ transplants.
Topics: Acyclovir; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Tolerance; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Incidence; Injections, Intravenous; Kidney Transplantation; Pancreas Transplantation; Placebos; Prednisone; Prospective Studies; Recurrence; Survival Rate; Tissue Donors; Transplantation, Homologous | 1993 |
FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis.
Topics: Adult; Anti-Infective Agents; Azathioprine; Contraindications; Creatinine; Dose-Response Relationship, Drug; Drug Resistance; Female; Follow-Up Studies; Ganciclovir; Graft Rejection; Graft Survival; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Muromonab-CD3; Steroids; Tacrolimus; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease.
Topics: Agammaglobulinemia; Antilymphocyte Serum; Antiviral Agents; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Heart Transplantation; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prednisone; Recurrence; Tacrolimus | 2005 |
Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.
Topics: Adult; Antiviral Agents; Azathioprine; Chemoprevention; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Renal Insufficiency; Risk Factors; Tacrolimus; Treatment Outcome | 2010 |
40 other study(ies) available for azathioprine and ganciclovir
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Ganciclovir treatment for cytomegalovirus infections in renal transplant recipients.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Female; Ganciclovir; Graft Rejection; Humans; Kidney Transplantation; Male; Methylprednisolone; Muromonab-CD3; Retrospective Studies | 1992 |
Survival of ganciclovir-treated heart transplant recipients with cytomegalovirus pneumonitis.
Topics: Adult; Azathioprine; Cyclosporine; Cytomegalovirus; Ganciclovir; Heart Transplantation; Humans; Immunosuppression Therapy; Middle Aged; Pneumonia, Viral; Prednisone; Treatment Outcome | 1991 |
Neutropenic enterocolitis in a renal transplant patient.
Topics: Azathioprine; Cyclosporine; Cytomegalovirus Infections; Enterocolitis; Ganciclovir; Humans; Kidney Transplantation; Male; Neutropenia; Peritoneal Dialysis, Continuous Ambulatory; Prednisolone | 1991 |
Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression.
Topics: Adult; Azathioprine; Biopsy; Creatinine; Female; Ganciclovir; Hemolytic-Uremic Syndrome; Humans; Kidney Transplantation; Prednisone; Tacrolimus | 1991 |
Diagnosis and treatment of cytomegalovirus disease in transplant patients based on gastrointestinal tract manifestations.
Topics: Abdominal Pain; Adult; Antilymphocyte Serum; Azathioprine; Bacterial Infections; Cyclosporins; Cytomegalovirus Infections; Diarrhea; Female; Fever; Ganciclovir; Gastrointestinal Diseases; Humans; Kidney Transplantation; Male; Middle Aged; Organ Transplantation; Recurrence | 1991 |
Treatment of renal transplant-associated cytomegalovirus infection with ganciclovir.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Cyclosporins; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Muromonab-CD3; Prednisolone; Viremia | 1990 |
Treatment of transplant rejection in the presence of cytomegalovirus viremia.
Topics: Azathioprine; Cyclosporins; Cytomegalovirus Infections; Ganciclovir; Graft Rejection; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Liver Transplantation; Methylprednisolone; Pancreas Transplantation; Viremia | 1990 |
Cytomegalovirus prophylaxis with ganciclovir, acyclovir, and CMV hyperimmune globulin in liver transplant patients receiving OKT3 induction.
Topics: Acyclovir; Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Humans; Immunoglobulins, Intravenous; Infant; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Postoperative Complications; Prednisone; Retrospective Studies | 1995 |
Sample preparation for the determination of purine nucleotide analogues in tissues.
Topics: Antimetabolites; Azathioprine; Chromatography, High Pressure Liquid; Ganciclovir; Guanine Nucleotides; Guanosine Triphosphate; Heart Transplantation; Humans; Inosine Monophosphate; Lung; Myocardium; Purine Nucleotides; Specimen Handling; Thionucleotides | 1996 |
Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children.
Topics: Adolescent; Age Factors; Antiviral Agents; Azathioprine; Child; Child, Preschool; Cyclosporine; Follow-Up Studies; Ganciclovir; Glucocorticoids; Graft Rejection; Herpesviridae Infections; Herpesvirus 4, Human; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Incidence; Liver Failure; Liver Transplantation; Lymphoproliferative Disorders; Methylprednisolone; Muromonab-CD3; Prednisone; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Tacrolimus; Tumor Virus Infections | 1997 |
Failure of ganciclovir prophylaxis of primary cytomegalovirus disease in immunologic high-risk recipients.
Topics: Adult; Antiviral Agents; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Prednisone; Retrospective Studies; Risk Factors; Survival Rate; Treatment Failure | 1998 |
Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients.
Topics: Acyclovir; Adult; Antiviral Agents; Azathioprine; Case-Control Studies; Cohort Studies; Cytomegalovirus Infections; Enteritis; Female; Ganciclovir; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Mycophenolic Acid; Pneumonia, Viral; Risk Factors; Severity of Illness Index | 2000 |
Failure of ganciclovir prophylaxis to completely eradicate CMV disease in renal transplant recipients treated with intense anti-rejection immunotherapy.
Topics: Adult; Antilymphocyte Serum; Antiviral Agents; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Mycophenolic Acid; Prednisone; Risk Factors | 2000 |
Active CMV infection before lung transplantation: risk factors and clinical implications.
Topics: Animals; Antilymphocyte Serum; Azathioprine; CD4-CD8 Ratio; Cyclophosphamide; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Preoperative Care; Rabbits; Retrospective Studies; Risk Factors; Urine | 2000 |
Cytomegalovirus-associated gastric ulcer in an immunosuppressed patient with pemphigus vulgaris.
Topics: Aged; Antiviral Agents; Azathioprine; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Immunocompromised Host; Immunosuppressive Agents; Pemphigus; Prednisolone; Ranitidine; Stomach Ulcer | 2001 |
Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction.
Topics: Acute Disease; Adolescent; Adult; Aged; Antiviral Agents; Azathioprine; Chronic Disease; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications | 2001 |
[Opportunistic infections in patients with inflammatory bowel disease undergoing immunosuppressive therapy].
Topics: Acyclovir; Adult; Aged; Antiviral Agents; Azathioprine; Chickenpox; Crohn Disease; Disease Susceptibility; Esophageal Diseases; Fatal Outcome; Female; Ganciclovir; Hepatitis, Viral, Human; Herpes Zoster; Herpesviridae Infections; Humans; Immunosuppressive Agents; Leukopenia; Lymphopenia; Male; Opportunistic Infections; Pneumonia, Viral | 2003 |
[Cytomegalovirus hepatitis and ductopenia in a heart transplant recipient].
Topics: Acute Disease; Antiviral Agents; Azathioprine; Bile Duct Diseases; Bile Ducts, Intrahepatic; Cytokines; Cytomegalovirus Infections; Drug Therapy, Combination; gamma-Globulins; Ganciclovir; Graft Rejection; Heart Transplantation; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Models, Biological; Mycophenolic Acid; Postoperative Complications; Ursodeoxycholic Acid | 2003 |
CMV enteritis causing ileal perforation in underlying lupus enteritis.
Topics: Adult; Anti-Inflammatory Agents; Antiviral Agents; Azathioprine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Enteritis; Female; Ganciclovir; Humans; Ileal Diseases; Ileum; Immunosuppressive Agents; Intestinal Perforation; Lupus Erythematosus, Systemic; Prednisolone; Tomography, X-Ray Computed | 2004 |
Multimodal immunosuppressant therapy in steroid-refractory common variable immunodeficiency sprue: a case report complicating cytomegalovirus infection.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antiviral Agents; Azathioprine; Celiac Disease; Common Variable Immunodeficiency; Cytomegalovirus; Cytomegalovirus Infections; Diagnosis, Differential; Drug Resistance; Duodenum; Female; Ganciclovir; Humans; Immunologic Factors; Immunosuppressive Agents; Infliximab; Lymphoma, T-Cell; Middle Aged; Prednisone; Steroids | 2006 |
Alemtuzumab induced complete remission of autoimmune hemolytic anemia refractory to corticosteroids, splenectomy and rituximab.
Topics: Alemtuzumab; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antigens, CD; Antigens, Neoplasm; Antiviral Agents; Azathioprine; Blood Transfusion; CD52 Antigen; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance; Ganciclovir; Glycoproteins; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Remission Induction; Rituximab; Splenectomy; Valganciclovir; Viremia; Virus Activation | 2006 |
Cytomegalovirus colitis complicating ulcerative colitis treated with adalimumab.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azathioprine; Colitis, Ulcerative; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Glucocorticoids; Humans; Immunosuppressive Agents | 2010 |
[Cytomegalovirus primary infection in a patient with Crohn's disease treated with azathioprine and anti-TNF alpha].
Topics: Adult; Antibodies, Monoclonal; Antiviral Agents; Azathioprine; Crohn Disease; Cytomegalovirus Infections; Ganciclovir; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Tumor Necrosis Factor-alpha | 2009 |
Cytomegalovirus colitis.
Topics: Acyclovir; Antiviral Agents; Azathioprine; Colitis; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Immunosuppressive Agents; Valacyclovir; Valine; Young Adult | 2012 |
Fever and pancytopenia in a patient with Crohn's disease.
Topics: Angiography; Antiviral Agents; Azathioprine; Cecum; Crohn Disease; Digestive System Surgical Procedures; Disease Progression; Female; Fever; Foscarnet; Ganciclovir; Gastrointestinal Hemorrhage; Humans; Ileitis; Ileum; Immunosuppression Therapy; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Male; Pancytopenia; Rectum; Treatment Outcome; Valganciclovir; Young Adult | 2013 |
Hickam's dictum in a patient with diarrhea.
Topics: Antiviral Agents; Azathioprine; Colitis; Cytomegalovirus Infections; Diarrhea; Female; Ganciclovir; Humans; Immunosuppressive Agents; Middle Aged; Mycophenolic Acid; Treatment Outcome | 2013 |
[Acute cytomegalovirus infection-associated hemophagocytic syndrome in a patient treated with azathioprine].
Topics: Antiviral Agents; Azathioprine; Colitis, Ulcerative; Colonoscopy; Combined Modality Therapy; Critical Care; Cytomegalovirus Infections; Febrile Neutropenia; Female; Ganciclovir; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lymphohistiocytosis, Hemophagocytic; Treatment Outcome; Young Adult | 2013 |
Ganciclovir-induced ataxia and encephalopathy.
Topics: Antiviral Agents; Ataxia; Azathioprine; Brain Diseases; Crohn Disease; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Immunocompromised Host; Immunosuppressive Agents; Middle Aged | 2016 |
Disseminated CMV infection and HLH in a patient with well-controlled HIV and ulcerative colitis.
Topics: Adrenal Cortex Hormones; Antiviral Agents; Azathioprine; Colitis, Ulcerative; Cytomegalovirus Infections; Ganciclovir; HIV Infections; Humans; Immunocompromised Host; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Treatment Outcome | 2019 |
CMV pneumonitis in a patient with Crohn's disease taking azathioprine.
Topics: Antiviral Agents; Azathioprine; Crohn Disease; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Pneumonia | 2021 |
Eosinophilic enteritis accompanied by cytomegalovirus disease: a case report.
Topics: Azathioprine; Cytomegalovirus; Cytomegalovirus Infections; Enteritis; Eosinophilia; Female; Ganciclovir; Gastritis; Humans; Hypoalbuminemia; Prednisolone | 2022 |